Detection of a Soluble Form of CD109 in Serum of CD109 Transgenic and Tumor Xenografted Mice

• Hiroki Sakakura,

  Affiliations Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan, Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

  ⨯
• Yoshiki Murakumo,

  Affiliations Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan, Department of Pathology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan

  ⨯
• Shinji Mii,

  Affiliation Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

  ⨯
• Sumitaka Hagiwara,

  Affiliation Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

  ⨯
• Takuya Kato,

  Affiliation Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

  ⨯
• Masato Asai,

  Affiliation Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

  ⨯
• Akiyoshi Hoshino,

  Affiliation Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

  ⨯
• Noriyuki Yamamoto,

  Affiliation Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

  ⨯
• Sayaka Sobue,

  Affiliation Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi, Japan

  ⨯
• Masatoshi Ichihara,

  Affiliation Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi, Japan

  ⨯
• Minoru Ueda,

  Affiliation Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

  ⨯
• Masahide Takahashi

  * E-mail: mtakaha@med.nagoya-u.ac.jp

  Affiliation Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

  ⨯